Study Links Polyendocrine Metabolic Ovarian Syndrome to Increased Cardiac Risk

New research published in The Lancet indicates that women diagnosed with polyendocrine metabolic ovarian syndrome (PMOS), previously known as PCOS, face a four-fold elevated risk of atherosclerotic cardiovascular disease events, including heart attacks and ischemic strokes. PMOS affects approximately 1 in 10 women in the U.S. This finding underscores the critical importance of early screening and targeted interventions to safeguard the cardiovascular health of this significant patient population.